Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

tendered and not withdrawn pursuant to the tender offer.

"We are excited about the combination of King and Alpharma, which will create a leading specialty pharmaceutical company with greater scale and capabilities," stated Brian A. Markison, Chairman, President and Chief Executive Officer of King. "Together, we will be better positioned to deliver superior value to our stockholders and significant benefits to employees of both companies. In addition, the transaction will create a stronger platform to deliver innovation to our customers. King and Alpharma are highly complementary and we look forward to even greater success as a combined company."

"The transformation of Alpharma over the past two years has created tremendous shareholder value, and we have consistently said that we will act in the best interest of shareholders," commented Dean Mitchell, Alpharma's President and Chief Executive Officer. "Therefore, after careful evaluation, our Board determined that a combination with King is in the best interest of our shareholders and provides them immediate access to this value. We believe the combined company has a compelling strategic logic and will create a strong company for both shareholders and employees. We look forward to working with King's team to integrate our companies."

King noted that Alpharma's Animal Health division will increase the diversification of King's business and is expected to provide steady cash flow to fuel future strategic initiatives, much like its Meridian auto-injector franchise. Additionally, King believes the strong commercialization capabilities that this combination provides will enhance the anticipated launches of REMOXY(R) (long-acting oral oxycodone) and EMBEDA(TM) (morphine sulfate extended-release with sequestered naltrexone hydrochloride), both of which are designed to resist or deter common methods of opioid misuse and abuse. Commercialization of these produc
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Follow us on LinkedIn ... and establish chronic pain rehabilitation centers are driving demand ... is poised to benefit from the rise in acute ... in chronic health conditions such as Cancer, degenerative diseases, ... While conventional treatment for pain management is dominated by ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 On March ... Ford Field, home of the Detroit Lions, LiveToBeSober.org hosted ... nationally recognized pastors, ministers and bishops as well as ... addressed the audience at the luncheon, including retired Detroit ... sponsor Per Wickstrom and two survivors of their own ...
(Date:3/30/2015)... Dr. Daniel Shapiro, one of the t ... on Phoenix’s Channel 12 News about the benefits of his ... alternative to facelifts developed by Dr. Shapiro. , Over the ... Aesthetic Plastic Surgery and Skin Klinic worked closely with 12 ... on GenXLift. The story detailed the experience and results of ...
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 On ... blue polo for yellow to inspire courage in Seth ... from Severe Combined Immunodeficiency (SCID). SCID causes affected individuals ... marrow transplant is needed to allow the development of ... transplant last Friday, created a video with his family ...
(Date:3/30/2015)... 2015 DMG Productions announces the upcoming ... broadcast on Monday, April 20, 2015 at 7:30 a.m. ... , In this episode Innovations will explore Limbkeepers® non ... fragile, thinning skin on arms, hands, and legs from ... on how their products help reduce injuries, allow for ...
Breaking Medicine News(10 mins):Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:New Episode of Innovations Airing Monday, April 20, 2015 Via Discovery Channel 2
... (HealthDay News) -- Personal independence and freedom are more important ... Researchers at the Victoria University of Wellington in New Zealand ... of more than 420,000 people from 63 countries and spanned ... autonomy, but it does not add to well-being or happiness." ...
... Where you get your news could play a significant ... strategy for addressing childhood obesity. According to a study ... of Public Health, whether you believe the keys to ... behavior changes or system-level factors such as marketing and ...
... from the United Kingdom cured well-established prostate tumors in ... effects. This novel cancer treatment approach encourages the immune ... from toxic chemotherapies and radiation treatments. Such a treatment ... free with fewer side effects than those experienced from ...
... -- Whether they are riding with an adult or just ... a running lawn mower, a doctor warns. "Kids should ... the age of 16 should not be allowed to operate ... Harris, pediatric podiatrist with the Loyola University Health System, said ...
... , FRIDAY, June 17 (HealthDay News) -- Last year, ... all U.S. counties, a new study shows. This trend, ... moving away, as well as decreases in fertility levels. Researchers ... (UNH) also found that rural areas are particularly hard hit ...
... LOUISVILLE, Ky. The first three patients to undergo ... involves the patient,s own stem cells continue to do ... the principal investigator. The "TGI-PVG IDE" clinical trial ... cells to line man-made bypass grafts to better the ...
Cached Medicine News:Health News:Freedom More Important to Happiness Than Wealth, Study Finds 2Health News:News source may steer perceived solution to childhood obesity 2Health News:News source may steer perceived solution to childhood obesity 3Health News:Mayo Clinic researchers use human vaccine to cure prostate cancer in mice 2Health News:Adults Reminded to Keep Kids Away From Lawn Mowers 2Health News:Deaths Exceed Births in 24% of U.S. Communities: Report 2Health News:University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care 2Health News:University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care 3Health News:University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care 4
(Date:3/30/2015)... YORK , March 30, 2015  Check-Cap Ltd. ... company focused on the development of a preparation-free ingestible ... for colorectal cancer, announced today that its CEO, Guy ... March 31, 2015 trading day.  Neev and Check-Cap will ... commemorate the company,s initial public offering and simultaneous private ...
(Date:3/30/2015)... Perrigo Company plc (NYSE: PRGO ; TASE), a ... announced that it has completed the acquisition of Belgian-based ... equity transaction valued at approximately €3.8 billion, which includes ... Marc Coucke , Waterland Private Equity Fund V ... "The combination of Perrigo and Omega creates an ...
(Date:3/30/2015)... 2015  MedAptus® today announced the launch of ... pre-care needs for busy inpatient provider teams. Assign ... patients to hospitalists or other rounding providers based ... requirements such as ensuring patient safety, proper reimbursement ... In an increasingly risk-based ...
Breaking Medicine Technology:Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: